Biotec Beta-Glucans

Biotec Beta-Glucans, a subsidiary of Lallemand, is a biotechnology company headquartered in Tromsø, Norway, that specializes in the development and manufacturing of high-purity beta-glucans derived from yeast. The company's proprietary M-Glucan technology is used to create bioactive products for human health, animal health, and wound care. Its lead medical product, Woulgan, is a bioactive wound healing gel designed for the treatment of chronic wounds such as diabetic foot ulcers and pressure ulcers. Biotec Beta-Glucans also provides specialty ingredients like M-Gard for immune support and Macrogard for animal health. Following its acquisition from ArcticZymes Technologies in 2020, the company continues to operate as a specialized unit within Lallemand's global portfolio.